Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232113604
Abstract: In patients with early-stage endocrine receptor-positive (ER+) breast cancer (BC), adjuvant endocrine therapy (ET) for 5 years is the standard of care. However, for some patients, the risk of recurrence remain high for up to… read more here.
Keywords: treatment luminal; luminal breast; breast; endocrine treatment ... See more keywords